About Toxikon
Toxikon is a Healthcare company based in Bedford (United States) founded in 1977, and was acquired by LabCorp in November 2021. It operates as a preclinical testing services for drugs and medical devices are provided. Toxikon offers products and services including Biocompatibility Testing, Microbiology Validation, Analytical Chemistry, and Efficacy and Surgical Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include Gentronix, Tigermed, BioQual, Shanghai Yaocheng Health Technology and ReveraGen and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Toxikon was established in 1977 in Bedford, United States, as a provider of preclinical services within the biotechnology sector. Testing and safety evaluations for pharmaceuticals and medical devices are conducted through various operations, including toxicology studies, biocompatibility assessments, and regulatory support. Services are tailored to ensure compliance with industry standards, with activities centered in the United States to support drug and device development processes.
Products & Services of Toxikon
Toxikon offers a comprehensive portfolio of products and services, including Biocompatibility Testing, Microbiology Validation, Analytical Chemistry, and Efficacy and Surgical Services.
Evaluates device materials for biological safety and compliance.
Assesses device sterility and reusability for regulatory standards.
Analyzes chemical composition of devices for safety and efficacy.
Conducts studies to confirm device performance in surgical models.
Apps and channels of Toxikon
its YouTube channel Labcorp has 6.37K subscribers and 30 videos.
Videos from Toxikon
The most watched videos on Toxikon's YouTube channel, Labcorp (6.37K subscribers). Click a video to play it here.
More on Labcorp .
Investors in Toxikon
Toxikon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for Toxikon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Toxikon
2 dated milestones of Toxikon across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Toxikon is founded.
- Exit Acquired by LabCorp.
Competitors of Toxikon
Toxikon has 9 listed competitors in our database, 5 of them funded. They include Gentronix, Tigermed, BioQual, Shanghai Yaocheng Health Technology and ReveraGen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gentronix.co.uk | 1999 | Alderley Edge, United Kingdom | $3.84M | 1 | In-vitro and in-vivo genetic toxicology screening services are provided. | |
| tigermedgrp.com | 2004 | Hangzhou, China | – | 15 | Drug development and preclinical services are provided by Tigermed. | |
| bioqual.com | 1981 | Rockville, United States | – | 193 | Contract research on infectious disease models is conducted. | |
| yaocheng.cn | 2020 | Shanghai, China | $15.44M | – | Clinical trial services to biopharma sector are provided. | |
| reveragen.com | 2008 | Rockville, United States | – | – | Steroids for Duchenne muscular dystrophy treatment are developed. | |
| simrbio.com | 2014 | Shanghai, China | $20.76M | – | Diversified preclinical services for brain-related disorders are provided. | |
| gubra.dk | 2008 | Horsholm, Denmark | – | – | Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | |
| phaxiam.com | 2004 | Lyon, France | $15.8M | – | Antibacterial treatments using bacteriophages are developed for resistant infections. | |
| bioseekinc.com | 2000 | San Francisco, United States | $10M | – | Provider of drug discovery services |
Detailed competitors of Toxikon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Toxikon
Websites that share an audience with Toxikon (toxikon.com).
Websites whose visitors overlap most with Toxikon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dudnyk.com | 100% | – | – | View details | |
careersinpharmaceutical.com | careersinpharmaceutical.com | 100% | – | #8,019,819 | – |
biodevelopment.com | biodevelopment.com | 99% | – | – | – |
biotechnologyjobs.com | biotechnologyjobs.com | 99% | – | – | – |
| hologic.com | 67% | 185.1K | #258,622 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Toxikon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Toxikon (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Toxikon
Complete news archive for Toxikon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Toxikon
Toxikon was founded in 1977.
Toxikon is headquartered in Bedford, United States.
Toxikon was established in 1977 in Bedford, United States, as a provider of preclinical services within the biotechnology sector. Testing and safety evaluations for pharmaceuticals and medical devices are conducted through various operations, including toxicology studies, biocompatibility assessments, and regulatory support. Services are tailored to ensure compliance with industry standards, with activities centered in the United States to support drug and device development processes.
Toxikon offers Biocompatibility Testing, Microbiology Validation, Analytical Chemistry, and Efficacy and Surgical Services.
Toxikon has 1 investor. Key investors include LabCorp.
Yes. Toxikon was acquired by LabCorp in November 2021.